DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 969 filers reported holding DANAHER CORPORATION in Q2 2015. The put-call ratio across all filers is 0.93 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $2,800,000 | +9.2% | 25,766 | -0.9% | 1.68% | +7.3% |
Q2 2018 | $2,565,000 | +2.7% | 25,991 | +1.9% | 1.57% | -5.0% |
Q1 2018 | $2,497,000 | +8.4% | 25,506 | +2.8% | 1.65% | +8.9% |
Q4 2017 | $2,304,000 | +7.8% | 24,823 | +13.2% | 1.51% | +2.0% |
Q3 2017 | $2,138,000 | -1.0% | 21,923 | -14.3% | 1.48% | -4.3% |
Q2 2017 | $2,159,000 | -1.1% | 25,583 | +0.2% | 1.55% | -6.1% |
Q1 2017 | $2,183,000 | +6.2% | 25,528 | -3.3% | 1.65% | -0.8% |
Q4 2016 | $2,056,000 | +2.3% | 26,411 | +3.0% | 1.66% | -1.7% |
Q3 2016 | $2,009,000 | -23.9% | 25,631 | -1.9% | 1.69% | -25.1% |
Q2 2016 | $2,639,000 | +1.5% | 26,133 | -4.7% | 2.26% | -0.1% |
Q1 2016 | $2,601,000 | +7.2% | 27,423 | +5.0% | 2.26% | +4.0% |
Q4 2015 | $2,426,000 | +14.9% | 26,123 | +5.4% | 2.18% | -0.9% |
Q3 2015 | $2,111,000 | +0.6% | 24,773 | +1.0% | 2.20% | +11.2% |
Q2 2015 | $2,098,000 | +15.1% | 24,518 | +13.6% | 1.97% | +7.7% |
Q1 2015 | $1,822,000 | -0.8% | 21,584 | +0.8% | 1.83% | -5.0% |
Q4 2014 | $1,836,000 | – | 21,421 | – | 1.93% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |